One of the main features of TRAIL resistance is the aberrantly high level of c-FLIP proteins expression, as described in HCC and in other many tumors [61,62] and indeed their targeting enhances TRAIL sensitivity [66]. Here, CFLAR is linked to hepatocellular carcinoma.